BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:Early Cancer Institute Seminar: Prof Utkan Demirci\, Department of
  Radiology at Stanford University School of Medicine and the Canary Center
  at Stanford for Cancer Early Detection Electrical Engineering (by courtes
 y).   - Prof Utkan Demirci\, Department of Radiology at Stanford Universit
 y School of Medicine and the Canary Center at Stanford for Cancer Early De
 tection Electrical Engineering (by courtesy).  
DTSTART:20241015T113000Z
DTEND:20241015T130000Z
UID:TALK221440@talks.cam.ac.uk
CONTACT:Catherine Atkins
DESCRIPTION:Micro and nanoscale technologies can have a significant impact
  on medicine and biology in the areas of cell manipulation\, diagnostics a
 nd monitoring. At the convergence of these new technologies and biology\, 
 we research for enabling solutions to real-world problems at the clinic. E
 merging nanoscale and microfluidic technologies integrated with biology of
 fer innovative possibilities for creating intelligent\, medical\, microflu
 idic lab-chip devices that could transform diagnostics and monitoring\, mi
 crorobotics\, tissue engineering and regenerative medicine. We will presen
 t interesting applications of microfluidic technologies in IVF\, applicati
 ons of extracellular vesicles in cancer.\n\n\n\nSpeaker Biography:\nDr. Ut
 kan Demirci\, UofM’99\, Stanford’01’05’05\, is a Professor of Radi
 ology (with tenure) and of Electrical Engineering (by courtesy) at the Can
 ary Center at Stanford for Cancer Early Detection\, Stanford University Sc
 hool of Medicine\, where he leads a productive researcher group. Utkan is 
 a tenured professor at Stanford University School of Medicine.\n\nPrior to
  joining Stanford in 2014\, he held the position of Associate Professor at
  the Brigham and Women’s Hospital-Harvard Medical School and also served
  at the Harvard-MIT Health Sciences and Technology division. Over the past
  decade\, his research group has focused on the early detection of cancer 
 and has made significant contributions to the development of microfluidic 
 platforms for sorting rare cells and exosomes and point-of-care biosensing
  technologies.\n\nUtkan leads a productive and impactful research group fo
 cused on addressing problems from the clinic with innovations including ce
 ll sorter for IVF\, optical technologies for detecting viruses\, portable 
 point of care technologies for diagnostics in global health\, smart robots
  in vivo\, extracellular vesicle based early detection approaches for canc
 er.\n\nHe is an elected fellow of the American Institute of Medical and Bi
 ological Engineering and The Academy for Radiology & Biomedical Imaging Re
 search Distinguished Investigator. He has published over 250 peer-reviewed
  articles\, 300 abstracts and proceedings\, 24 book chapters and editorial
 s\, and 7 edited books. He also serves on the editorial board of various j
 ournals. He holds 15 patents (11 of which are translated into biomedical p
 roducts) and has co-founded 5 companies. Dr. Demirci's pioneering work in 
 microfluidic cell sorting has resulted in CE certified and FDA approved mi
 crofluidic devices used in over 500\,000 clinical cases and readily access
 ible in over 1000+ IVF clinics serving patients globally.
LOCATION: Jeffrey Cheah Biomedical Centre Lecture Theatre
END:VEVENT
END:VCALENDAR